Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ketamine alters rat flash evoked potentials.

G C Rigdon1, R S Dyer

  • 1United States Environmental Protection Agency, Neurotoxicology Division/Neurophysiology Branch, Research Triangle Park, NC 27711.

Pharmacology, Biochemistry, and Behavior
|June 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator.

Molecular pharmacology·2007
Same author

International Arctic Seas Assessment Project.

The Science of the total environment·1999
Same author

Synthesis and evaluation of heterocyclic carboxamides as potential antipsychotic agents.

Journal of medicinal chemistry·1996
Same author

1192U90 in animal tests that predict antipsychotic efficacy, anxiolysis, and extrapyramidal side effects.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·1996
Same author

What can research contribute to regulatory decisions about the health risks of multiple chemical sensitivity?

Regulatory toxicology and pharmacology : RTP·1996
Same author

Structure-activity relationships of a series of substituted benzamides: potent D2/5-HT2 antagonists and 5-HT1a agonists as neuroleptic agents.

Journal of medicinal chemistry·1996
Same journal

Chronic psilocin microdosing produces limited behavioral effects and does not enhance neurogenesis in rats.

Pharmacology, biochemistry, and behavior·2026
Same journal

Modulation of prefrontal NMDA receptors reveals pharmacogenetic differences between SHR and SLA16 rat strains.

Pharmacology, biochemistry, and behavior·2026
Same journal

Spontaneous oxycodone withdrawal alters behavior and oligodendrocyte-related gene expression in mice.

Pharmacology, biochemistry, and behavior·2026
Same journal

Improvement in depressive symptoms in people undergoing cognitive behavioral therapy who supplemented with probiotics: An open-label, pilot study.

Pharmacology, biochemistry, and behavior·2026
Same journal

Long-term follow-up of children with autism spectrum disorder and severe treatment-resistant behavioral symptoms treated with purified cannabidiol.

Pharmacology, biochemistry, and behavior·2026
Same journal

Fluoxetine reduces anxiety-like behavior but increases motor impairments in the early stages of a progressive model of Parkinson's disease.

Pharmacology, biochemistry, and behavior·2026
See all related articles

Ketamine alters flash evoked potentials (FEPs) in rats, suggesting excitatory amino acids like glutamate may be involved in visual neurotransmission. This research aids understanding neurological damage assessment.

Area of Science:

  • Neuroscience
  • Visual System Physiology
  • Neuropharmacology

Background:

  • Flash evoked potentials (FEPs) are crucial for assessing neurological damage.
  • Excitatory amino acids, glutamate and aspartate, are implicated as neurotransmitters in the visual system.
  • Ketamine is an N-methyl-D-aspartate receptor antagonist with potential systemic administration.

Purpose of the Study:

  • To investigate the role of excitatory amino acids in FEP generation.
  • To determine the effects of ketamine on rat FEPs.
  • To explore ketamine's potential as a tool for understanding visual neurotransmission.

Main Methods:

  • Two experiments were conducted on rats using varying ketamine doses (37, 75, 150 mg/kg).
  • FEPs were recorded in light and dark backgrounds at different post-treatment intervals (5, 10, 30 min).

Related Experiment Videos

  • Analysis focused on dose-dependent and time-dependent alterations in FEP peak amplitudes and latencies.

    • Main Results:

    • Ketamine caused dose-dependent changes in FEP peak amplitudes and latencies.
    • Peak P1 amplitude significantly increased, while Peak N1 amplitude decreased, with ketamine administration.
    • Specific effects on P2, N3 amplitudes, and latencies varied with ketamine dose, background light, and time post-administration.

    Conclusions:

    • Ketamine administration significantly alters rat FEPs, supporting the involvement of excitatory amino acids in their generation.
    • Findings suggest ketamine's utility in studying the neurochemical basis of visual processing and neurological damage.
    • Further research is warranted to elucidate the precise role of glutamate and aspartate in FEPs.